Cell>Point said it has filed with the FDA an investigational new drug application for a Phase Ib/II study of its 99mTc-EC-G imaging agent, which will be used in patients with cardiovascular conditions. The study aims to prove the potential of the agent as an alternative to standard myocardial perfusion imaging agents.
The Molecular Imaging and Contrast Agent Database has added nine new agents to its list, including agents for SPECT, PET, magnetic resonance and optical imaging. The database currently has 814 agents. The MICAD guest author program also is calling on imaging community members to forward write-ups on various agents for publication.
The NIH's Molecular imaging and contrast agent database has added 13 imaging agents for PET, SPECT and MRI. MICAD is part of the NIH Roadmap's Molecular Libraries and Imaging program. It now includes 796 agents.